Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IOI Corporation is a major Malaysian conglomerate that serves the life sciences and healthcare industries primarily through its oleochemical division, IOI Oleochemical. The company is a leading global producer of pharmaceutical-grade excipients, including medium-chain triglycerides (MCTs), hard fats, and fatty acid esters, which are essential for drug formulation and delivery. Operating high-standard GMP manufacturing facilities in Malaysia and Germany (IOI Oleo GmbH), the company provides critical ingredients for oral, topical, and parenteral pharmaceuticals. Its products, marketed under industry-standard brands such as MIGLYOL and SOFTISAN, are widely utilized by global pharmaceutical and personal care companies for specialized drug delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IOI Corporation.